Contract research organization ALMEDIS
E-mail:
info@almedis.ru
Tel: +7 495 937 43 18
Fax: +7 495 937 43 19
Address: 5, Ulitsa Malaya Pirogovskaya, office 22, 119435 Moscow, Russia

RUS ENG
About Us
Our Services
Quality
Contact Us
News
Links
Career

ALMEDIS is an independent contract research organization (CRO) with operations all over Russia

ALMEDIS provides comprehensive range of services in international and local clinical trials, observational studies, data management, biostatistics, medical writing and training programs.

Our CRO is committed to meeting the needs and expectations of our clients by providing professional and superior quality service, with integrity, reliability and strong client focus.

ALMEDIS is a member of the Association of Clinical Trial Organizations (ACTO).

    ALMEDIS is an Effective Resource for:
  • International pharmaceutical companies
  • International contract research organizations (CROs)
  • Pharmaceutical and biotech companies launching their clinical research activities in Russia
  • Scientific research organizations

Since 2007 ALMEDIS team has successfully managed more than 100 projects, including international and local Phase II - IV clinical trials and observational studies.

This year ALMEDIS marks the decade of successful collaboration with a leading international Life Sciences technology provider Ennov

          Latest News:
  • The Database lock was reached in the bioequivalence study of an anticancer drug.
  • The efforts of a group of Russian experts, including representatives of Almedis, were crowned with success - the next version of the dictionary for coding medical terms MedDRA 22.0 includes Russian language
    https://www.meddra.org/sites/default/files/messenger/documents/000308_messenger_march_2019.pdf
    https://www.meddra.org/news-and-events/messenger
  • Almedis, as a member of the Roszdravnadzor working group, participated in the preparation of materials for the training program for employees of territorial bodies of Roszdravnadzor, “Good clinical practice. Methodological basis of the inspection. The release of the program is scheduled for April 2019.

 




ALMEDIS is solely responsible for this site content. This information is intended for use by our customers and clinical research specialists.
© 2006-2018 ALMEDIS All rights reserved 

Privacy Policy